Jermaine D Jones (Jermaine Jones)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Topics

Quality Improvement

Top Venues

Expert opinion on investigational drugs

The American journal on addictions

Drugs (Abingdon, England)

Drug and alcohol review

This page only lists publications with an associated author ORCID identifier.

Publications

Rachel Luba, Suky Martinez, Jermaine D Jones, Marco Pravetoni, Sandra D Comer
Immunotherapeutic strategies for treating opioid use disorder and overdose. Expert opinion on investigational drugs 32 (1) (2023)
Rachel Luba, Suky Martinez, Jermaine D Jones, Marco Pravetoni, Sandra D Comer
Immunotherapeutic strategies for treating opioid use disorder and overdose. Expert opinion on investigational drugs 32 (1) (2023)
Suky Martinez, Albert Garcia-Romeu, Freymon Perez, Jermaine D Jones
Resilience Phenotypes and Psychological Functioning among Individuals with Opioid Use Disorder. Substance use & misuse (2023)
Rachel Luba, Suky Martinez, Jermaine D Jones, Marco Pravetoni, Sandra D Comer
Immunotherapeutic strategies for treating opioid use disorder and overdose. Expert opinion on investigational drugs 32 (1) (2023)
Jermaine D Jones, Jesus R Avila, Mitchell K Smith, Suky Martinez
Opioid overdose knowledge among college students compared to experienced opioid users. Drug and alcohol review (2023)
Rachel Luba, Suky Martinez, Jermaine D Jones, Marco Pravetoni, Sandra D Comer
Immunotherapeutic Strategies for Treating Opioid Use Disorder and Overdose. Expert opinion on investigational drugs (2023)
Rachel Luba, Suky Martinez, Jermaine D Jones, Marco Pravetoni, Sandra D Comer
Immunotherapeutic strategies for treating opioid use disorder and overdose. Expert opinion on investigational drugs 32 (1) (2023)
Rachel Luba, Suky Martinez, Jermaine D Jones, Marco Pravetoni, Sandra D Comer
Immunotherapeutic strategies for treating opioid use disorder and overdose. Expert opinion on investigational drugs (2023)
Rachel Luba, Suky Martinez, Jermaine D Jones, Marco Pravetoni, Sandra D Comer
Immunotherapeutic strategies for treating opioid use disorder and overdose. Expert opinion on investigational drugs 32 (1) (2023)
Rachel Luba, Jermaine D Jones, C Jean Choi, Sandra Comer
Fentanyl Withdrawal: Understanding Symptom Severity and Exploring the Role of BMI on Withdrawal Symptoms and Clearance. Addiction (Abingdon, England) (2022)
Laura Brandt, Aimee N C Campbell, Jermaine D Jones, Suky Martinez, Joanne Neale, Stephen Parkin, Caral Brown, Sir John Strang, Sandra D Comer
Emotional reactions of trained overdose responders who use opioids following intervention in an overdose event. Substance abuse (2021)
Joanne Neale, Adrian Farrugia, Aimee N C Campbell, Paul M Dietze, Robyn Dwyer, Renae Fomiatti, Jermaine D Jones, Sandra D Comer, Suzanne Fraser, Sir John Strang
UNDERSTANDING PREFERENCES FOR TYPE OF TAKE-HOME NALOXONE DEVICE: INTERNATIONAL QUALITATIVE ANALYSIS OF THE VIEWS OF PEOPLE WHO USE OPIOIDS. Drugs (Abingdon, England) 29 (2) (2021)
Suky Martinez, Jermaine D Jones, Laura Brandt, Aimee N C Campbell, Rebecca Abbott, Sandra D Comer
The Increasing Prevalence of Fentanyl: A Urinalysis-Based Study Among Individuals With Opioid Use Disorder in New York City. The American journal on addictions 30 (1) (2020)
Jermaine D Jones, Elliana Sherwin, Suky Martinez, Sandra D Comer
Naloxone-Induced Withdrawal in Individuals With and Without Fentanyl-Positive Urine Samples. The American journal on addictions 29 (1) (2019)
Jermaine D Jones, Jonathan S Vogelman, Rachel Luba, Mudassir Mumtaz, Sandra D Comer
Chronic pain and opioid abuse: Factors associated with health-related quality of life. The American journal on addictions 26 (8) (2017)